Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Key issues in non-viral gene delivery

Identifieur interne : 002270 ( Main/Exploration ); précédent : 002269; suivant : 002271

Key issues in non-viral gene delivery

Auteurs : Colin W. Pouton [Royaume-Uni] ; Leonard W. Seymour [Royaume-Uni]

Source :

RBID : ISTEX:148465397C35AADB72BA90B4AC4A01DF987F55FD

English descriptors

Abstract

Abstract: The future of non-viral gene therapy depends on a detailed understanding of the barriers to delivery of polynucleotides. These include physicomechanical barriers, which limit the design of delivery devices, physicochemical barriers that influence self-assembly of colloidal particulate formulations, and biological barriers that compromise delivery of the DNA to its target site. It is important that realistic delivery strategies are adopted for early clinical trials in non-viral gene therapy. In the longer term, it should be possible to improve the efficiency of gene delivery by learning from the attributes which viruses have evolved; attributes that enable translocation of viral components across biological membranes. Assembly of stable, organized virus-like particles will require a higher level of control than current practice. Here, we summarize present knowledge of the biodistribution and cellular interactions of gene delivery systems and consider how improvements in gene delivery will be accomplished in the future.

Url:
DOI: 10.1016/S0169-409X(00)00133-2


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Key issues in non-viral gene delivery</title>
<author>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W" last="Pouton">Colin W. Pouton</name>
</author>
<author>
<name sortKey="Seymour, Leonard W" sort="Seymour, Leonard W" uniqKey="Seymour L" first="Leonard W" last="Seymour">Leonard W. Seymour</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:148465397C35AADB72BA90B4AC4A01DF987F55FD</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0169-409X(00)00133-2</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-BMB34MH8-L/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001412</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001412</idno>
<idno type="wicri:Area/Istex/Curation">001412</idno>
<idno type="wicri:Area/Istex/Checkpoint">001093</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001093</idno>
<idno type="wicri:doubleKey">0169-409X:2001:Pouton C:key:issues:in</idno>
<idno type="wicri:Area/Main/Merge">002294</idno>
<idno type="wicri:Area/Main/Curation">002270</idno>
<idno type="wicri:Area/Main/Exploration">002270</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Key issues in non-viral gene delivery</title>
<author>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W" last="Pouton">Colin W. Pouton</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY</wicri:regionArea>
<wicri:noRegion>Bath BA2 7AY</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Seymour, Leonard W" sort="Seymour, Leonard W" uniqKey="Seymour L" first="Leonard W" last="Seymour">Leonard W. Seymour</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
<orgName type="university">Université de Birmingham</orgName>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Advanced Drug Delivery Reviews</title>
<title level="j" type="abbrev">ADR</title>
<idno type="ISSN">0169-409X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">46</biblScope>
<biblScope unit="issue">1–3</biblScope>
<biblScope unit="page" from="187">187</biblScope>
<biblScope unit="page" to="203">203</biblScope>
</imprint>
<idno type="ISSN">0169-409X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0169-409X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acad</term>
<term>Adult mouse</term>
<term>Aerosol delivery</term>
<term>Airway</term>
<term>Airway epithelia</term>
<term>Alveolar macrophages</term>
<term>Amphipathic helices</term>
<term>Apical surface</term>
<term>Biodistribution</term>
<term>Biodistribution routes</term>
<term>Biol</term>
<term>Biological barriers</term>
<term>Blood circulation</term>
<term>Blood components</term>
<term>Blood pressure</term>
<term>Brosis</term>
<term>Cancer gene therapy</term>
<term>Capillary permeability</term>
<term>Cationic</term>
<term>Cationic component</term>
<term>Cationic gene delivery</term>
<term>Cationic gene transfer</term>
<term>Cationic lipid</term>
<term>Cationic lipids</term>
<term>Cationic lipoplexes</term>
<term>Cationic liposome</term>
<term>Cationic particles</term>
<term>Cationic polymer</term>
<term>Cationic polymers</term>
<term>Cell culture systems</term>
<term>Cell transfection</term>
<term>Cellular interactions</term>
<term>Cftr gene transfer</term>
<term>Charge ratio</term>
<term>Chem</term>
<term>Chloroquine</term>
<term>Clinical indication</term>
<term>Condensed particles</term>
<term>Considerable interest</term>
<term>Critical issue</term>
<term>Cystic</term>
<term>Degradative pathway</term>
<term>Deliv</term>
<term>Delivery</term>
<term>Delivery systems</term>
<term>Direct gene transfer</term>
<term>Direct injection</term>
<term>Drug carrier syst</term>
<term>Drug deliv</term>
<term>Drug delivery</term>
<term>Drug delivery reviews</term>
<term>Drug delivery scientists</term>
<term>Elsevier science</term>
<term>Endosomal</term>
<term>Endosomal compartment</term>
<term>Endosome</term>
<term>Endothelium</term>
<term>Epithelium</term>
<term>Eukaryotic cells</term>
<term>Gene</term>
<term>Gene delivery</term>
<term>Gene delivery systems</term>
<term>Gene expression</term>
<term>Gene expression systems</term>
<term>Gene medicine</term>
<term>Gene products</term>
<term>Gene therapy</term>
<term>Gene transfer</term>
<term>Hashida</term>
<term>High concentrations</term>
<term>High levels</term>
<term>Higher levels</term>
<term>Hydrophilic polymers</term>
<term>Injection</term>
<term>Injection site</term>
<term>Intracellular</term>
<term>Intramuscular injection</term>
<term>Intravenous</term>
<term>Intravenous administration</term>
<term>Intravenous injection</term>
<term>Kupffer cells</term>
<term>Lipid</term>
<term>Lipid membranes</term>
<term>Lipoplexes</term>
<term>Liposome</term>
<term>Liposome complexes</term>
<term>Local effect</term>
<term>Local injection</term>
<term>Lung biology</term>
<term>Lung endothelia</term>
<term>Lung epithelia</term>
<term>Lung epithelium</term>
<term>Lung surfactant</term>
<term>Lymphatic drainage</term>
<term>Lymphatic system</term>
<term>Macromolecule</term>
<term>Major determinant</term>
<term>Many cells</term>
<term>Marcel dekker</term>
<term>Molecular complexes</term>
<term>Molecular motors</term>
<term>Molecular weight</term>
<term>Mouse models</term>
<term>Mouse muscle</term>
<term>Nagase rats</term>
<term>Nasal epithelium</term>
<term>Natl</term>
<term>Nuclear envelope</term>
<term>Nuclear import</term>
<term>Nuclear membrane</term>
<term>Nuclear pore</term>
<term>Nucleic acids</term>
<term>Partial correction</term>
<term>Particle bombardment</term>
<term>Particulate systems</term>
<term>Passive process</term>
<term>Pharm</term>
<term>Pharmaceutical products</term>
<term>Pharmacokinetic considerations</term>
<term>Plasma clearance</term>
<term>Plasma membrane</term>
<term>Plasmid</term>
<term>Polyelectrolyte complexes</term>
<term>Polymer</term>
<term>Pouton</term>
<term>Proc</term>
<term>Proton sponge hypothesis</term>
<term>Receptor</term>
<term>Reporter gene</term>
<term>Scavenger receptors</term>
<term>Seymour</term>
<term>Simian virus</term>
<term>Sodium glycocholate</term>
<term>Solid tissues</term>
<term>Solid tumours</term>
<term>Starburst dendrimers</term>
<term>Systemic circulation</term>
<term>Systemic delivery</term>
<term>Takakura</term>
<term>Target cells</term>
<term>Target site</term>
<term>Transfecting activity</term>
<term>Transfection</term>
<term>Trends cell biol</term>
<term>Tumour</term>
<term>Tumour tissue</term>
<term>Uptake</term>
<term>Vesicle</term>
<term>Vesicular stage</term>
<term>Viruslike particles</term>
<term>Vivo</term>
<term>Vivo transfection</term>
<term>Xenopus oocytes</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The future of non-viral gene therapy depends on a detailed understanding of the barriers to delivery of polynucleotides. These include physicomechanical barriers, which limit the design of delivery devices, physicochemical barriers that influence self-assembly of colloidal particulate formulations, and biological barriers that compromise delivery of the DNA to its target site. It is important that realistic delivery strategies are adopted for early clinical trials in non-viral gene therapy. In the longer term, it should be possible to improve the efficiency of gene delivery by learning from the attributes which viruses have evolved; attributes that enable translocation of viral components across biological membranes. Assembly of stable, organized virus-like particles will require a higher level of control than current practice. Here, we summarize present knowledge of the biodistribution and cellular interactions of gene delivery systems and consider how improvements in gene delivery will be accomplished in the future.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Midlands de l'Ouest</li>
</region>
<settlement>
<li>Birmingham</li>
</settlement>
<orgName>
<li>Université de Birmingham</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W" last="Pouton">Colin W. Pouton</name>
</noRegion>
<name sortKey="Seymour, Leonard W" sort="Seymour, Leonard W" uniqKey="Seymour L" first="Leonard W" last="Seymour">Leonard W. Seymour</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002270 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002270 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:148465397C35AADB72BA90B4AC4A01DF987F55FD
   |texte=   Key issues in non-viral gene delivery
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021